DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/23236w/metastatic_liver_c) has announced the addition of Global Markets Direct's new report "Metastatic Liver Cancer - Pipeline Review, H2 2012" to their offering.
This report provides information on the therapeutic development for Metastatic Liver Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Metastatic Liver Cancer. 'Metastatic Liver Cancer - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.
Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope:
- A snapshot of the global therapeutic scenario for Metastatic Liver Cancer.
- A review of the Metastatic Liver Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Metastatic Liver Cancer pipeline on the basis of route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
List of Tables and Figures 6
Metastatic Liver Cancer Overview 8
Therapeutics Development 9
An Overview of Pipeline Products for Metastatic Liver Cancer 9
Metastatic Liver Cancer Therapeutics under Development by Companies 11
Metastatic Liver Cancer Therapeutics under Investigation by Universities/Institutes 13
Late Stage Products 17
Comparative Analysis 17
Mid Clinical Stage Products 18
Comparative Analysis 18
Early Clinical Stage Products 19
Comparative Analysis 19
Discovery and Pre-Clinical Stage Products 20
Comparative Analysis 20
Metastatic Liver Cancer Therapeutics - Products under Development by Companies 21
Metastatic Liver Cancer Therapeutics - Products under Investigation by Universities/Institutes 22
Companies Involved in Metastatic Liver Cancer Therapeutics Development 24
Metastatic Liver Cancer - Therapeutics Assessment 32
Assessment by Monotherapy Products 32
Assessment by Combination Products 33
Assessment by Route of Administration 34
Assessment by Molecule Type 36
Drug Profiles 38
Metastatic Liver Cancer Therapeutics - Drug Profile Updates 129
Metastatic Liver Cancer Therapeutics - Discontinued Products 135
Metastatic Liver Cancer Therapeutics - Dormant Products 136
Metastatic Liver Cancer - Product Development Milestones 137
Featured News & Press Releases 137
Appendix 141
For more information visit http://www.researchandmarkets.com/research/23236w/metastatic_liver_c
Source: Global Markets Direct